Skip to content

Erasca, Inc. ERAS Total Assets

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Pfizer logo
PfizerPFE
$207.62B-0.2%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$2.25B-4.7%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$435.79M+58.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s total assets?
Erasca, Inc. (ERAS) reported total assets of $461.23M in Q1 2026.
How has Erasca, Inc.'s total assets changed year-over-year?
Erasca, Inc.'s total assets decreased by 2.1% year-over-year, from $471.24M to $461.23M.
What is the long-term trend for Erasca, Inc.'s total assets?
Over 5 years (2020 to 2025), Erasca, Inc.'s total assets has grown at a 26.0% compound annual growth rate (CAGR), from $124.83M to $396.15M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.